1[1]Turner L,Swindell R, Bell W. Radical versus modified radical mastectomy for breast cancer[J].Ann R Coll Surg Engl,1981,63:239
2[2]Maddox W,Carpenter J, Laws H, et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients[J]. Ann Surg,1983,198:207
3[3]Maddox W,Carpenter J, Laws H, et al. Does radical mastectomy still have a place in the treatment of primary operable breast cancer[J]? Arch Surg,1987,122:1317
4[4]Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast[J]. N Engl J Med,1981,305:6
5[5]Veronesi U,Banfi S, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer:long term results of a randomized clinical trial[J]. Eur J Cancer,1990,26:688
6[6]Fisher B, Anderson S, Redmond C, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trail comparing total mastectomy with lumpectomy with and without irradiation in the treatment of breast cancer. N Engl J Med,1995,333:1456
7[7]Van Dongen J, Bartelink H, Fentimen I, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage Ⅰ and Ⅱ breast cancer,EORTC 10801 trial[J]. J Natl Cancer Inst Monogr,1992,11:15
8[8]Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy:results from a randomised trial. Radiother Oncol,1996,39:233
9[9]Patel RT,Webster DJT,Mansel RE, et al. Is immediate postmastectomy reconstruction safe in the long-term[J]? Eur J Surg Oncol,1993,19:372
10[10]Schneider W,Hill L, Brown R. Latissimus dorsi myocutaneous flap for breast reconstruction[J]. Br J Plastic Surg,1981,30;286
6HENDERSON C, BERRY D A, DEMETRI G D, et al. Improved outcome from adding sequential paclitaxel but not from escalating doxorubicin does in an adjuvant chemotherapy regimen for patients with node-positive primary breatst cancer[J]. Clin Oncol , 2003,21:976-983.
7FULLER K,WONG B, FOX S,et al. Trance is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts[J]. J Exp Med, 1998,188(5) : 997-1001.
8KONG Y Y, YOSHIDA H, SAROSI I, et al, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis [J]. Nature, 1999,397 (6717 ) : 315-323.
9BUCAY N, SAROSI I, DUNSTAN C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J]. Genes Dev, 1998, 12(9): 1260-1268.
10BOYCE B F, XING L. Functions of RANKL/RANK/OPG in bone modeling and remodeling [ J ]. Arch Biochem Biophys, 2008,473 (2) : 139-146.
